The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome

Epilepsy Research

Volumn 34, Issue 2-3, 1999, Pages 91-97

  Siegel, Heidi ^a   Kelley, Kathleen ^a   Stertz, Barbara ^a   Reeves Tyer, Patricia ^a   Flamini, Robert ^a   Malow, Beth ^a   Gaillard, William D ^a   Ko, David ^a   Theodore, William H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Anticonvulsant drugs; Atonic seizures; FBM; Lennox Gastaut; VPA

Indexed keywords

CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; FELBAMATE; MESUXIMIDE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LENNOX GASTAUT SYNDROME; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; INCIDENCE; MALE; PROPYLENE GLYCOLS; SYNDROME; TELEVISION; VALPROIC ACID;

EID: 0032919338     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00119-3     Document Type: Article

References (21)

1. Allarakhia I.N., Garofalo E.A., Komarynski M.A., Roberson P.L. VPA and thrombocytopenia in children: a case-controlled retrospective study. Pediatr. Neurol. 14(4):1996;303-307.
2. Anon. The Felbamate Study Group in Lennox-Gastaut syndrome, efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). New Engl. J. Med. 328(1):1993;29-33.
3. Anon. FDA recommends taking patients off Felbatol [news]. RDH. 14(9):1994;36.
4. Anon. Felbamate linked to aplastic anemia; warning issued on drug's use. Am. J. Hosp. Pharm. 51(19):1994;2324.
5. Dodson W.E. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial. Epilepsia. 34(Suppl. 7):1993;18-24.
6. Gastaut H., Roger J., Soulayrol R., Tassinari C.A., Regis H., Dravet C., Bernard R., Pusard N., Saint-Jean M. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as 'petit mal variant' or Lennox syndrome). Epilepsia. 7:1966;139-179.
7. Graves N.M., Holmes G.B., Fuerst R.H., Leppik I.E. Effect of felbamate on phenytoin and carbamazepine serum concentrations. Epilepsia. 30(2):1989;225-229.
8. Graves N.M. Felbamate. Ann. Pharmacother. 27:1993;1073-1081.
9. Hauser E., Seidl R., Freilinger M., Male C., Herkner K. Hematologic manifestations and impaired synthetic function during VPA monotherapy. Brain Dev. 18(2):1996;105-109.
10. Hrachovy R.A., Frost J.D. Severe encephalopathic epilepsy in infants: infantile spasms. Dodson W.E., Pellock J.M. Pediatric Epilepsy: Diagnosis and Therapy. 1993;140 Demos, New York.
11. Hurst D.L., Rolan T.D. The use of felbamate to treat infantile spasms. J. Child Neurol. 10:1995;134-135.
12. Jensen P.K. Felbamate in the treatment of Lennox-Gastaut syndrome. Epilepsia. 35(Suppl. 5):1994;S34-S37.
13. Kellaway P., Hrachovy R.A., Frost J.D., Zion T. Precise characterization and quantification of infantile spasms. Ann. Neurol. 6:1979;214-218.
14. Nightingale S.L. Recommendation to immediately withdraw patients from treatment with felbamate. J. Am. Med. Assoc. 272(13):1994;995.
15. Palmer K.J., McTavish D. Felbamate: a review of its pharmacodynamic properties, and therapeutic efficacy in epilepsy. Drugs. 45(6):1993;1041-1065.
16. Pellock J.M., Brodie M.J. Felbamate: 1997 update. Epilepsia. 38(12):1997;1261-1264.
17. Rho J.M., Donevan S.D., Rogawski M.A. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and ?-aminobutyric acid a receptors. Ann. Neurol. 35(2):1994;229-234.
18. Romeo A., Viri M., Gonago E.F., Bonardi R., Viani F. Felbamate in patients with Lennox-Gastaut syndrome. Epilepsia. 37(Suppl. 4):1996;74.
19. Swingard E.A., Sofia R.D., Kupferberg H.J. Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Epilepsia. 27(1):1986;27-34.
20. Theodore W.H, Jensen PK, Kwan R.M.F. Felbamate: clinical use. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic Drugs. 1995;817-822 Raven, New York.
21. White H.S., Wolf H.H., Swinyard E.A., Skeen G.A., Sofia R.D. A neuropharmacogical evaluation of felbamate as a novel anticonvulsant. Epilepsia. 33(3):1992;564-572.